first generation anti-inflammatory compounds (Arch Biopartners)

N/A

Report date: 2025/03/20 14:47:46
NME

Base Information

Drug Namefirst generation anti-inflammatory compounds (Arch Biopartners)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArch Biopartners Inc
China Registration ClassN/A

Develop Information

Active CompaniesArch Biopartners Inc
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A